Andere talen Consolidated Gems, Inc.

Aandelen

Vertraagde tijd OTC Markets Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^USD	-.--%		-.--%	-.--%

01/05	CONSOLIDATED GEMS, INC. : Stifel Nicolaus geeft koopadvies	ZM
29/04	Cullinan Therapeutics benoemt Mary Kay Fenton tot CFO	MT

Cullinan Therapeutics Appoints Mary Kay Fenton as CFO	29/04
Cullinan Oncology Finance Chief Jeffrey Trigilio to Leave	14/03
Cullinan Oncology Secures FDA Approval for CLN-619's Investigational New Drug Application in Multiple Myeloma	01/03
Cullinan Oncology Insider Sold Shares Worth $647,200, According to a Recent SEC Filing	05/02
Cullinan Oncology Insider Sold Shares Worth $563,600, According to a Recent SEC Filing	31/01
Cullinan Oncology Doses First Patient in Study of Advanced Solid Tumor Treatment Candidate	15/12
Insider Sell: Cullinan Oncology	08-06-23
Cullinan Oncology Gets FDA Clearance for CLN-617 Study	27-03-23
Cullinan Oncology's Q4 Loss Narrows	09-03-23
Cullinan Oncology to Pay $25 Million for License Agreement With Harbour BioMed	14-02-23
Cullinan Oncology Says US FDA Approves Investigational New Drug Application for CLN-978	24-01-23
Cullinan Oncology Posts Wider Q3 Loss; Cash, Equivalents Decline	14-11-22
Cullinan Oncology Raises Stake in Cullinan MICA Unit to 92%	25-10-22
Cullinan Oncology Swings to Profit in Q2	10-08-22
Insider Sell: Cullinan Oncology	26-07-22
Insider Sell: Cullinan Oncology	21-07-22
Cullinan Oncology Finalizes Collaboration Deal With Taiho Pharmaceutical	23-06-22
Insider Buy: Cullinan Oncology	07-06-22
Cullinan Oncology Q1 Net Loss Narrows	16-05-22
Earnings Flash (CGEM) CULLINAN ONCOLOGY Posts Q1 Loss $-0.27	16-05-22

Geen resultaten voor deze zoekopdracht